Over 90% of ocular medications are administered by eye drops despite multiple drawbacks including low bioavailability of the target therapeutic, systemic toxicity, and the requirement for using high doses due to the effective clearance mechanisms for drug in the eye. To increase the therapeutic efficacy of ocular medications, novel nanocarrier systems have been developed that […]
Read More